clear selections
clear selections
clear selections
  • Policy and Technical Changes to the Medicare Advantage Program

    Rubrum Advising | 01.26.2026

    Rubrum Advising appreciates the opportunity to comment on the Centers for Medicare and Medicaid Services (CMS) 2027 proposed policy and technical changes to the Medicare Advantage (MA) Program and accompanying Request for Information (RFI). Rubrum Advising (“Rubrum”), founded by Lee Fleisher, MD, former CMS Chief Medical Officer and Director of the Center for Clinical Standards and Quality, advises clients on matters pertaining to the adoption, diffusion, and reimbursement of innovative solutions and products to improve patient outcomes and reduce total costs of healthcare within the context of regulation, safety, quality, and clinical standards.

  • RAPIDS Network Recommendations for Quality Measure Development and Revision

    Rubrum Advising | 12.08.2025

    The RAPIDS Network Quality Measures Working Group convened to recommend new quality measures that capture previous gaps in antimicrobial stewardship and infection prevention & control data collection and measurement.

  • RAPIDS Network Recommendations for Quality Measure Prioritization

    Rubrum Advising | 12.08.2025

    Among the measures that were recommended for revision, the group identified those in the Value-Based Purchasing (VBP) program that may result in inappropriate penalization and should therefore be temporarily removed while undergoing revision or replacement, with continued inclusion in the Hospital Inpatient Quality Reporting (IQR) program.

  • RAPIDS Network Inpatient Prospective Payment Systems (IPPS) Proposed Rule Response

    Rubrum Advising | 12.08.2025

    The RAPIDS Network believes that increased interoperability can strike the balance between the important need for reporting public health data to Federal, State, and local officials and the administrative burden that falls on health systems to do so.

  • RAPIDS Network Recommendations to Further the Goals of the Infection Prevention and Control and Antibiotic Stewardship Program Conditions of Participation

    Rubrum Advising | 12.08.2025

    The RAPIDS (Regulation And Policy for Infectious Disease Stewardship) Network is co-convened by Rubrum Advising, the Federation of American Hospitals (FAH), and the Association of American Medical Colleges (AAMC). Members include a variety of infectious disease stakeholders whose goal is to improve the quality of care for patients in hospitals through the enhancement of Antimicrobial Stewardship Programs (ASPs).

  • Rubrum Advising Welcomes Former CMS Coverage and Analysis Group (CAG) Director Tamara Syrek Jensen as Vice President of Federal Programs

    Rubrum Advising | 09.15.2025

    Rubrum Advising, a fast-growing health policy, regulatory, and market access firm, today announced Tamara Syrek Jensen, JD, has joined the firm as Vice President of Federal Programs.

  • The Rubrum Philosophy: Using clinical expertise to solve market access challenges

    Lee A. Fleisher | 08.06.2025

    Two years in, Rubrum Advising’s North Star remains clear: helping patients access meaningful, high-impact care by aligning innovation with the clinical knowledge, regulatory frameworks, and policy trends that deliver it.

    • Corporate
    • Article
    • Lee Fleisher
  • Rubrum Advising Launches Government Affairs Practice Led by Former CMS and HHS Executive Thomas Corry

    Rubrum Advising | 06.11.2025

    Rubrum Advising, a boutique firm rooted in clinical practice and dedicated to developing healthcare market access, regulatory and policy strategies that demonstrate the value of groundbreaking innovations to payers and providers, today announced the launch of a new government affairs and advocacy practice.

    • Press Release
    • Corporate
    • Gov-Affairs
  • LEADING HEALTH GROUPS LAUNCH EFFORT TO ENCOURAGE MODERNIZATION OF HEALTH SCREENING MEASURES

    Rubrum Advising | 06.04.2025

    The Alliance for Screening Measurement Modernization (ASMM) brings together organizations from across the healthcare sector to explore a broader framework for the timely integration of evidence into currently endorsed national health screening policies.

    • ASMM
    • Press Release
    • Policy
  • Empowering Clinicians with the Latest FDA-Approved Screening Technologies

    Lee Fleisher, M.D., M.L. | 06.04.2025

    In the U.S., a significant barrier to ensuring high quality health care is our very complex regulatory environment. As the pace of innovation continues increasing rapidly, it is critical that our policy infrastructure evolves to meet the moment.

    • ASMM
    • Policy